申请人:John Varghese
公开号:US20050182138A1
公开(公告)日:2005-08-18
Dipeptide derived inhibitors of the β-secretase enzyme are provided which are useful in the treatment of Alzheimer's disease and other diseases characterized by deposition of Aβ peptide in a mammal. The compounds of the invention provide useful methods of treatment by administration of these inhibitors to reduce Aβ peptide formation and in pharmaceutical compositions.
本发明提供了来源于二肽的β-分泌酶抑制剂,其在治疗老年痴呆症和其他在哺乳动物体内沉积Aβ肽的疾病中非常有用。本发明的化合物通过给药这些抑制剂来减少Aβ肽的形成,并在制药组合物中提供有用的治疗方法。